Introduction to Human Topoisomerase I

Human Topoisomerase I is an essential nuclear enzyme responsible for resolving topological stress generated during critical cellular processes such as DNA replication, transcription, chromatin remodeling, recombination, and chromosome segregation. During these processes, DNA molecules become overwound or supercoiled, creating torsional strain that can interfere with genome stability and gene expression. Human topoisomerase I solves these topological problems by transiently cleaving one strand of the DNA duplex, allowing controlled rotation and relaxation of supercoiled DNA before religating the broken strand.

Unlike type II topoisomerases, which cleave both strands of DNA simultaneously, type I topoisomerases introduce a transient single-strand break. This controlled nicking and resealing mechanism preserves genomic integrity while permitting rapid structural adjustments in DNA architecture. The catalytic activity of human topoisomerase I depends on a highly conserved tyrosine residue that attacks the phosphodiester backbone of DNA, forming a transient covalent enzyme-DNA intermediate.

The structural and mechanistic characterization of human topoisomerase I has become increasingly important because of its central biological role and its relevance as a therapeutic target in anticancer chemotherapy. Several clinically important anticancer drugs, including camptothecin derivatives, specifically target the transient cleavage complex formed by topoisomerase I and DNA, thereby inducing lethal DNA damage in rapidly dividing tumor cells.

Structural Organization of Human Topoisomerase I

The structural analysis of human topoisomerase I revealed a sophisticated multidomain architecture specifically adapted for DNA recognition, cleavage, rotation, and religation. Crystallographic investigations of an NH2-terminally truncated 70-kDa form of the enzyme, commonly referred to as topo70, provided important insights into the catalytic mechanism of the enzyme and the structural dynamics associated with DNA relaxation.

The topo70 construct contains amino acid residues from Lys175 to Phe765 and forms a stable noncovalent complex with double-stranded DNA. Unlike previously studied reconstituted enzyme structures, this model includes the important linker domain located between residues Pro636 and Lys712, allowing a more complete understanding of enzyme flexibility and DNA interaction.

The overall structure demonstrates that the enzyme forms a clamp-like architecture surrounding the DNA duplex. The core and COOH-terminal domains embrace the DNA helix, creating a positively charged central channel that complements the negatively charged phosphate backbone of DNA.

Linker Domain Architecture

One of the most important discoveries in the structural analysis of human topoisomerase I was the characterization of the linker domain. This region consists primarily of two long antiparallel α-helices connected by a short turn, forming a coiled-coil structure.

The linker domain exhibits several important structural features:

• Extensive hydrophobic leucine-leucine interactions stabilize the coiled-coil
• Multiple salt bridges reinforce interhelical interactions
• Strong heptad-repeat organization supports structural rigidity
• The DNA-facing surface possesses a highly positive electrostatic charge
• The opposite surface displays a more balanced distribution of positive and negative charges

The asymmetric distribution of surface charges strongly suggests that the linker domain participates directly in regulating DNA movement during topoisomerization.

Structural similarity analyses demonstrated remarkable resemblance between the linker domain and bacterial coiled-coil proteins such as the Rop protein and the GreA transcription factor despite minimal sequence identity. This observation highlights the evolutionary conservation of structural motifs involved in nucleic acid interactions.

DNA Recognition and Enzyme-DNA Interactions

Human topoisomerase I interacts with DNA through extensive electrostatic complementarity. The DNA duplex is positioned within a positively charged central cavity formed by the core and COOH-terminal domains.

Interestingly, structural studies revealed that many positively charged residues located on the linker domain and the so-called “nose cone” helices point toward the DNA but do not directly contact the phosphate backbone. This observation was highly significant because it suggested that these positively charged surfaces may guide or regulate DNA movement rather than statically bind the duplex.

Two major positively charged regions were identified:

1. The linker domain surface
2. The nose cone helices of the core subdomains

These regions appear strategically positioned to influence rotational movement of DNA during relaxation.

The arrangement supports a dynamic interaction model in which electrostatic forces transiently guide DNA rotation while avoiding excessively tight binding that would inhibit strand movement.

Catalytic Mechanism of DNA Cleavage

The catalytic center of human topoisomerase I is composed of several highly conserved amino acid residues that coordinate phosphodiester bond cleavage and religation.

The critical catalytic residue is Tyr723. During catalysis, the hydroxyl group of Tyr723 performs nucleophilic attack on the scissile phosphodiester bond of DNA.

The attack results in:

• Cleavage of one DNA strand
• Formation of a covalent phosphotyrosine intermediate
• Temporary storage of DNA cleavage energy within the phosphotyrosine bond
• Preservation of genomic continuity during strand rotation

Several conserved residues stabilize the transition state during catalysis:

• Arg488
• Arg590
• His632

These amino acids interact with the nonbridging oxygen atoms of the scissile phosphate and help stabilize the pentavalent transition state formed during cleavage.

The catalytic mechanism likely proceeds through the following sequence:

1. DNA binding and clamp closure
2. Activation of Tyr723
3. Nucleophilic attack on the phosphodiester bond
4. Formation of the covalent intermediate
5. Controlled rotational relaxation of DNA
6. Religation of the broken strand
7. Release of relaxed DNA

Controlled Rotation Model of DNA Relaxation

One of the most important outcomes of the structural studies was the proposal of the “controlled rotation” model for DNA relaxation.

Historically, two competing mechanisms had been proposed for topoisomerase I activity:

Free Rotation Model

This model proposed that after cleavage, the downstream DNA segment rotates freely around the intact strand to dissipate supercoiling.

Strand Passage Model

This mechanism proposed that the intact DNA strand passes through a transient enzyme-mediated gate formed by the cleaved strand.

However, structural analysis of human topoisomerase I suggested that neither extreme model fully explained the observed molecular architecture.

Instead, the structural data supported an intermediate mechanism known as controlled rotation.

Evidence Supporting Controlled Rotation

Several observations favored the controlled rotation mechanism:

Limited DNA Contacts

The enzyme does not tightly grip DNA downstream of the cleavage site. This weak interaction would permit rotational flexibility.

Positively Charged Helical Surfaces

The linker helices and nose cone helices create electrostatic surfaces capable of transiently regulating DNA rotation through ionic interactions.

Structural Constraints

Modeling studies demonstrated that unrestricted free rotation would generate severe steric clashes between DNA and protein domains.

Flexible Linker Domain

The coiled-coil linker region appears capable of shifting relative to the core domains, providing dynamic regulation of DNA movement.

These findings collectively indicate that DNA rotation is neither fully unrestricted nor mechanically gated but instead carefully modulated by transient electrostatic interactions.

Proposed Topoisomerization Cycle

The complete catalytic cycle of human topoisomerase I can be described in multiple coordinated stages.

1. DNA Binding

The enzyme initially adopts an open conformation that permits duplex DNA entry into the positively charged central cavity.

2. Clamp Closure

The core subdomains close around the DNA helix, positioning catalytic residues near the scissile phosphate.

3. DNA Cleavage

Tyr723 attacks the phosphodiester bond, forming a covalent intermediate.

4. Controlled DNA Rotation

Superhelical tension drives rotational movement of the downstream DNA segment while positively charged helices regulate rotational speed and direction.

5. DNA Religation

The 5′ hydroxyl group attacks the phosphotyrosine linkage, restoring phosphodiester continuity.

6. Enzyme Release

The relaxed DNA molecule dissociates, allowing the enzyme to initiate another catalytic cycle.

Structural Flexibility and Crystal Properties

Crystallographic analysis of topo70-DNA complexes revealed substantial conformational variability.

The crystals exhibited:

• High mosaic spread
• Significant nonisomorphism
• Variable monoclinic lattice dimensions
• Flexible linker positioning

These observations suggest that the linker domain possesses considerable dynamic mobility, which may be functionally important for DNA relaxation.

The flexibility likely allows the enzyme to accommodate different superhelical states and dynamically regulate torsional stress during catalysis.

Evolutionary Conservation of Catalytic Residues

Sequence comparisons among eukaryotic and viral type I topoisomerases revealed remarkable conservation of catalytic residues.

Highly conserved amino acids include:

• Tyr723
• Arg488
• Arg590
• His632

The conservation of these residues across diverse organisms indicates that the catalytic mechanism of phosphodiester cleavage evolved early and has remained fundamentally unchanged throughout evolution.

This evolutionary conservation also emphasizes the essential biological importance of controlled DNA topology management.

Biological Importance of Human Topoisomerase I

Human topoisomerase I is indispensable for maintaining genomic stability and facilitating proper chromosome function.

Its biological roles include:

• Relieving transcription-associated supercoiling
• Preventing replication fork collapse
• Facilitating chromatin remodeling
• Supporting recombination processes
• Assisting chromosome segregation during mitosis

Disruption of topoisomerase I activity can lead to:

• DNA strand breaks
• Replication stress
• Chromosomal instability
• Cell cycle arrest
• Apoptosis

Because cancer cells exhibit elevated replication and transcriptional activity, they are particularly sensitive to topoisomerase I inhibition.

Clinical Significance and Anticancer Therapeutics

Human topoisomerase I is a major target of anticancer chemotherapy.

Drugs derived from Camptothecin stabilize the covalent topoisomerase I-DNA intermediate, preventing religation and converting transient DNA breaks into permanent lesions during replication.

Clinically important topoisomerase I inhibitors include:

• Irinotecan
• Topotecan

These agents are widely used for treating:

• Colorectal cancer
• Ovarian cancer
• Small-cell lung cancer
• Cervical cancer

Understanding the structural mechanism of topoisomerase I has therefore contributed directly to rational drug design and cancer therapeutics.

Conclusion

Structural and biochemical investigations of human topoisomerase I have provided a detailed molecular model for DNA relaxation through controlled strand cleavage and regulated rotational movement. The enzyme functions as a dynamic molecular clamp that transiently cleaves DNA using a conserved tyrosine-mediated transesterification reaction.

The discovery of the coiled-coil linker domain and its positively charged surfaces strongly supports the controlled rotation mechanism of DNA relaxation. Rather than permitting unrestricted free rotation or performing classical strand passage, human topoisomerase I appears to regulate torsional relaxation through carefully orchestrated electrostatic interactions between DNA and flexible protein domains.

These discoveries significantly advanced our understanding of DNA topology regulation, enzyme catalysis, and genome maintenance. In addition, they provided the structural foundation for the development of clinically important anticancer drugs targeting the topoisomerase I cleavage complex.

Ongoing structural, biochemical, and computational studies continue to refine our understanding of the conformational dynamics and mechanistic complexity of this essential enzyme system.